Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition

Francois Renault-Mihara, Hiroyuki Katoh, Takeshi Ikegami, Akio Iwanami, Masahiko Mukaino, Akimasa Yasuda, Satoshi Nori, Yo Mabuchi, Hirobumi Tada, Shinsuke Shibata, Ken Saito, Masayuki Matsushita, Kozo Kaibuchi, Seiji Okada, Yoshiaki Toyama, Masaya Nakamura, Hideyuki Okano

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The migratory response of astrocytes is essential for restricting inflammation and preserving tissue function after spinal cord injury (SCI), but the mechanisms involved are poorly understood. Here, we observed stimulation of in vitro astrocyte migration by the new potent glycogen synthase kinase-3 (GSK-3) inhibitor Ro3303544 and investigated the effect of Ro3303544 administration for 5 days following SCI in mice. This treatment resulted in accelerated migration of reactive astrocytes to sequester inflammatory cells that spared myelinated fibres and significantly promoted functional recovery. Moreover, the decreased extent of chondroitin sulphate proteoglycans and collagen IV demonstrated that scarring was reduced in Ro3303544-treated mice. A variety of in vitro and in vivo experiments further suggested that GSK-3 inhibition stimulated astrocyte migration by decreasing adhesive activity via reduced surface expression of β1-integrin. Our results reveal a novel benefit of GSK-3 inhibition for SCI and suggest that the stimulation of astrocyte migration is a feasible therapeutic strategy for traumatic injury in the central nervous system.

Original languageEnglish
Pages (from-to)682-696
Number of pages15
JournalEMBO Molecular Medicine
Volume3
Issue number11
DOIs
Publication statusPublished - 2011 Nov

Fingerprint

Glycogen Synthase Kinase 3
Astrocytes
Spinal Cord
Spinal Cord Injuries
Chondroitin Sulfate Proteoglycans
Integrins
Adhesives
Cicatrix
Collagen
Central Nervous System
Inflammation
Wounds and Injuries

Keywords

  • Astrocyte
  • Glial scar
  • GSK-3
  • Migration
  • Spinal cord injury

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition. / Renault-Mihara, Francois; Katoh, Hiroyuki; Ikegami, Takeshi; Iwanami, Akio; Mukaino, Masahiko; Yasuda, Akimasa; Nori, Satoshi; Mabuchi, Yo; Tada, Hirobumi; Shibata, Shinsuke; Saito, Ken; Matsushita, Masayuki; Kaibuchi, Kozo; Okada, Seiji; Toyama, Yoshiaki; Nakamura, Masaya; Okano, Hideyuki.

In: EMBO Molecular Medicine, Vol. 3, No. 11, 11.2011, p. 682-696.

Research output: Contribution to journalArticle

Renault-Mihara, F, Katoh, H, Ikegami, T, Iwanami, A, Mukaino, M, Yasuda, A, Nori, S, Mabuchi, Y, Tada, H, Shibata, S, Saito, K, Matsushita, M, Kaibuchi, K, Okada, S, Toyama, Y, Nakamura, M & Okano, H 2011, 'Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition', EMBO Molecular Medicine, vol. 3, no. 11, pp. 682-696. https://doi.org/10.1002/emmm.201100179
Renault-Mihara, Francois ; Katoh, Hiroyuki ; Ikegami, Takeshi ; Iwanami, Akio ; Mukaino, Masahiko ; Yasuda, Akimasa ; Nori, Satoshi ; Mabuchi, Yo ; Tada, Hirobumi ; Shibata, Shinsuke ; Saito, Ken ; Matsushita, Masayuki ; Kaibuchi, Kozo ; Okada, Seiji ; Toyama, Yoshiaki ; Nakamura, Masaya ; Okano, Hideyuki. / Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition. In: EMBO Molecular Medicine. 2011 ; Vol. 3, No. 11. pp. 682-696.
@article{c740c48a5fc64b5492c1f1c8133a6771,
title = "Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition",
abstract = "The migratory response of astrocytes is essential for restricting inflammation and preserving tissue function after spinal cord injury (SCI), but the mechanisms involved are poorly understood. Here, we observed stimulation of in vitro astrocyte migration by the new potent glycogen synthase kinase-3 (GSK-3) inhibitor Ro3303544 and investigated the effect of Ro3303544 administration for 5 days following SCI in mice. This treatment resulted in accelerated migration of reactive astrocytes to sequester inflammatory cells that spared myelinated fibres and significantly promoted functional recovery. Moreover, the decreased extent of chondroitin sulphate proteoglycans and collagen IV demonstrated that scarring was reduced in Ro3303544-treated mice. A variety of in vitro and in vivo experiments further suggested that GSK-3 inhibition stimulated astrocyte migration by decreasing adhesive activity via reduced surface expression of β1-integrin. Our results reveal a novel benefit of GSK-3 inhibition for SCI and suggest that the stimulation of astrocyte migration is a feasible therapeutic strategy for traumatic injury in the central nervous system.",
keywords = "Astrocyte, Glial scar, GSK-3, Migration, Spinal cord injury",
author = "Francois Renault-Mihara and Hiroyuki Katoh and Takeshi Ikegami and Akio Iwanami and Masahiko Mukaino and Akimasa Yasuda and Satoshi Nori and Yo Mabuchi and Hirobumi Tada and Shinsuke Shibata and Ken Saito and Masayuki Matsushita and Kozo Kaibuchi and Seiji Okada and Yoshiaki Toyama and Masaya Nakamura and Hideyuki Okano",
year = "2011",
month = "11",
doi = "10.1002/emmm.201100179",
language = "English",
volume = "3",
pages = "682--696",
journal = "EMBO Molecular Medicine",
issn = "1757-4676",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition

AU - Renault-Mihara, Francois

AU - Katoh, Hiroyuki

AU - Ikegami, Takeshi

AU - Iwanami, Akio

AU - Mukaino, Masahiko

AU - Yasuda, Akimasa

AU - Nori, Satoshi

AU - Mabuchi, Yo

AU - Tada, Hirobumi

AU - Shibata, Shinsuke

AU - Saito, Ken

AU - Matsushita, Masayuki

AU - Kaibuchi, Kozo

AU - Okada, Seiji

AU - Toyama, Yoshiaki

AU - Nakamura, Masaya

AU - Okano, Hideyuki

PY - 2011/11

Y1 - 2011/11

N2 - The migratory response of astrocytes is essential for restricting inflammation and preserving tissue function after spinal cord injury (SCI), but the mechanisms involved are poorly understood. Here, we observed stimulation of in vitro astrocyte migration by the new potent glycogen synthase kinase-3 (GSK-3) inhibitor Ro3303544 and investigated the effect of Ro3303544 administration for 5 days following SCI in mice. This treatment resulted in accelerated migration of reactive astrocytes to sequester inflammatory cells that spared myelinated fibres and significantly promoted functional recovery. Moreover, the decreased extent of chondroitin sulphate proteoglycans and collagen IV demonstrated that scarring was reduced in Ro3303544-treated mice. A variety of in vitro and in vivo experiments further suggested that GSK-3 inhibition stimulated astrocyte migration by decreasing adhesive activity via reduced surface expression of β1-integrin. Our results reveal a novel benefit of GSK-3 inhibition for SCI and suggest that the stimulation of astrocyte migration is a feasible therapeutic strategy for traumatic injury in the central nervous system.

AB - The migratory response of astrocytes is essential for restricting inflammation and preserving tissue function after spinal cord injury (SCI), but the mechanisms involved are poorly understood. Here, we observed stimulation of in vitro astrocyte migration by the new potent glycogen synthase kinase-3 (GSK-3) inhibitor Ro3303544 and investigated the effect of Ro3303544 administration for 5 days following SCI in mice. This treatment resulted in accelerated migration of reactive astrocytes to sequester inflammatory cells that spared myelinated fibres and significantly promoted functional recovery. Moreover, the decreased extent of chondroitin sulphate proteoglycans and collagen IV demonstrated that scarring was reduced in Ro3303544-treated mice. A variety of in vitro and in vivo experiments further suggested that GSK-3 inhibition stimulated astrocyte migration by decreasing adhesive activity via reduced surface expression of β1-integrin. Our results reveal a novel benefit of GSK-3 inhibition for SCI and suggest that the stimulation of astrocyte migration is a feasible therapeutic strategy for traumatic injury in the central nervous system.

KW - Astrocyte

KW - Glial scar

KW - GSK-3

KW - Migration

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=80155191211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80155191211&partnerID=8YFLogxK

U2 - 10.1002/emmm.201100179

DO - 10.1002/emmm.201100179

M3 - Article

VL - 3

SP - 682

EP - 696

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

SN - 1757-4676

IS - 11

ER -